Max Lataillade – Biography
Last update: 24 days agoExecutive profile
Max was Vice President and Head of Early Development and Global Research Strategy at ViiV Healthcare, and Vice President and Head of Global Development HIV at Bristol-Myers Squibb. Max Lataillade joined CytoDyn in 2024.
Max Lataillade is currentlySenior Vice President and Head of Clinical Development at CytoDyn - View - CytoDyn org chart
Create your alert
to follow the career of Max Lataillade.
Education
Max Lataillade has a Medical Residency from Temple University.
They have also studied at Temple University :
Find more alumni from Temple University
More about Max Lataillade
Selected links
Do you need to know more about Max Lataillade? More results.
Participate
Social media
- Max Lataillade on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Max Lataillade
The colleagues of Max Lataillade
Company Colleagues
- At CytoDyn, Max Lataillade has 12 colleagues including Jacob Lalezari (CEO), Stephen Simes (Director)…
Industry Colleagues
- In the Biotechnology industry, Max Lataillade has 35,755 colleagues in 2,406 companies located in 42 countries. 16,856 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Max Lataillade.
Get in Touch
Here are a few tips for establishing great contacts.
